Indirubin inhibits tumor growth by antitumor angiogenesis via blocking VEGFR2‐mediated JAK/STAT3 signaling in endothelial cell
Open Access
- 4 January 2011
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 129 (10), 2502-2511
- https://doi.org/10.1002/ijc.25909
Abstract
Tumor angiogenesis is one of the hallmarks of the development in malignant neoplasias and metastasis. Many angiogenesis inhibitors are small molecules from natural products. Indirubin, the active component of a traditional Chinese herbal medicine, Banlangen, has been shown to exhibit antitumor and anti‐inflammation effects. But its roles in tumor angiogenesis, the key step involved in tumor growth and metastasis, and the involved molecular mechanism is unknown. Here, we identified that indirubin inhibited prostate tumor growth through inhibiting tumor angiogenesis. Using chick chorioallantoic membrane (CAM) assay and mouse corneal model, we found that indirubin inhibited angiogenesis in vivo. We also showed the inhibition activity of indirubin in endothelial cell migration, tube formation and cell survival in vitro. Furthermore, indirubin suppressed vascular endothelial growth factor receptor 2‐mediated Janus kinase (JAK)/STAT3 signaling pathway but had little effects on the activity of extracellular signal‐regulated kinase (ERK) and p38 mitogen‐activated protein kinase in endothelial cell. Our study provided the first evidence for antitumor angiogenesis activity of indirubin and the related molecular mechanism. Our investigations suggested that indirubin was a potential drug candidate for angiogenesis related diseases.This publication has 39 references indexed in Scilit:
- Selective targeting of adenovirus to αvβ3 integrins, VEGFR2 and Tie2 endothelial receptors by angio-adenobodiesInternational Journal of Pharmaceutics, 2010
- Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesisNature, 2010
- Herbal Compound Farnesiferol C Exerts Antiangiogenic and Antitumor Activity and Targets Multiple Aspects of VEGFR1 (Flt1) or VEGFR2 (Flk1) Signaling CascadesMolecular Cancer Therapeutics, 2010
- Tumor angiogenesis – A potential target in cancer chemopreventionFood and Chemical Toxicology, 2008
- Regulation of VEGF-mediated angiogenesis by the Akt/PKB substrate GirdinNature, 2008
- Vascular endothelial growth factor receptor-2: Structure, function, intracellular signalling and therapeutic inhibitionCellular Signalling, 2007
- STAT3: A critical transcription activator in angiogenesisMedicinal Research Reviews, 2007
- LC-APCI-MS method for detection and analysis of tryptanthrin, indigo, and indirubin in Daqingye and BanlangenJournal of Pharmaceutical and Biomedical Analysis, 2007
- Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cellsProceedings of the National Academy of Sciences of the United States of America, 2005
- Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathwayOncogene, 2003